Evaluation gene group and corresponding kit used for prognosis prediction of gastric cancer

Abstract

The invention discloses an evaluation gene group and corresponding kit used for prognosis prediction of gastric cancer. The evaluation gene group and corresponding kit comprise a shell upper cover and an upper layer fixing frame, the rear end of the upper surface of the shell upper cover is rotationally connected with the rear surface of a shell through hinges, a constant temperature controller is fixedly connected to the middle position of the lower end of the front surface of the shell, through holes are evenly formed in the upper layer fixing frame, a lower layer fixing frame is arranged under the upper layer fixing frame, and through holes are evenly formed in the lower layer fixing frame. By arranging the constant temperature controller and a compressor, control over the temperature in the kit can be achieved, so that reagents in the kit are within the temperature range with activity; through the arrangement of a rubber cushion, test tubes can be fixed and placed more stably, and labels on the outer sides of the test tubes can be protected from being scratched easily; and through the arrangement of a waterproof film, the waterproof film is filled with harmless liquid, temperature conduction can be more uniform, and a certain heat preservation effect is achieved when the kit is transferred.

Description

technical field [0001] The invention belongs to the technical field of kits, and in particular relates to an evaluation gene group used for prognosis prediction of gastric cancer and a corresponding kit. Background technique [0002] The kit is a box used to contain chemical reagents such as chemical components, drug residues, and virus types. It is generally used by hospitals and pharmaceutical companies. In gastric cancer, the mutation analysis of the whole exome genome found that the RhoA gene is in gastric cancer. The mutation rate of gastric cancer is higher, especially in the diffuse subtype of gastric cancer, there is mutation enrichment. However, the prognosis of RhoA mutation was analyzed by survival analysis, and the prognosis was established with the mutation of RhoA gene alone for survival analysis, and no significant relationship was found. Therefore, only the RhoA gene can be used to correlate the prognosis of gastric cancer, which cannot meet the needs of pre...

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide an evaluation gene group and a corresponding kit for prognostic prediction of gastric cancer, to solve the problem that the general kits proposed in the above background technology are clearly classified, marked with clear methods of use and information, but the kit itself Less functions, unable to control the temperature in the kit, some reagents can only be stored at a certain temperature, and need to be placed in other constant temperature containers, and a small number of fixing racks in the kits do not have a device to protect the test tube, which is easy to cause damage to the test tube The problem

Images